EUVIMEDEUVIMED entdecken
Crossref

The Persistence of Racial Representation Disparity in Head and Neck Cancer Clinical Trials in the United States: A Temporal Analysis of 20 Years of Data

Lalita Sabat iD, Arnavaz Hajizadeh Barfejani, Grace Chow, Melani Zuckerman, Jungwun Lee, Heather Edwards, Gintas P Krisciunas

Head & Neck · 2026

DOI: 10.1002/hed.70197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2026. Verfasst von Lalita Sabat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Boston Medical Center Department of Otolaryngology Head and Neck Surgery, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Ethnicity, Head and Neck Neoplasms, Healthcare Disparities. Die Arbeit nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Significant racial disparities in survival outcomes exist among Head and Neck Cancer (HNC) patients. Building upon Zuckerman et al., this current study assessed temporal changes in HNC clinical trial enrollment in the context of changing racial/ethnic disease prevalence.

Methods

One hundred seven eligible HNC clinical trials were analyzed from 2002 to 2020. Participant demographics were categorized into five standardized racial/ethnic groups aligned with SEER database classifications. Differences in racial group enrollment rates were investigated using boxplots and scatterplots stratified by race and year, and with multiple linear regression.

Results

White participants were overrepresented and minority groups were consistently underrepresented: Black (−0.121, 95% CI: [−0.145, −0.095]), Hispanic (−0.174, 95% CI: [−0.199, −0.149]), Asian/Pacific Islander (−0.129, 95% CI: [−0.155, −0.105]), and American Indian/Alaska Native (−0.104, 95% CI: [−0.128, −0.079]).

Conclusion

Collectively, this data supports the need for new approaches that facilitate equitable representation, needed to improve HNC treatment outcomes across all demographic groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicEthnicityHead and Neck NeoplasmsHealthcare DisparitiesRacial GroupsHumansHispanic or LatinoSEER ProgramUnited StatesWhiteBlack or African AmericanAmerican Indian or Alaska NativeAsian American Native Hawaiian and Pacific Islander

Stichwörter der Autor:innen

clinical trial reviewhead and neck cancerhealth equityracial factors

Autor:innen und Institutionen

  • Boston Medical Center Department of Otolaryngology Head and Neck Surgery, Boston, Massachusetts, USA.
  • Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
  • University of Colorado Anschutz School of Medicine, Aurora, Colorado, USA.
  • Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
  • Boston University School of Public Health, Boston, Massachusetts, USA.

ORCID-Profile: Lalita Sabat

Zitieren

APA

Sabat, L., Barfejani, A. H., Chow, G., Zuckerman, M., Lee, J., Edwards, H., & Krisciunas, G. P. (2026). The Persistence of Racial Representation Disparity in Head and Neck Cancer Clinical Trials in the United States: A Temporal Analysis of 20 Years of Data. Head & Neck. https://doi.org/10.1002/hed.70197

Vancouver

Sabat L, Barfejani AH, Chow G, Zuckerman M, Lee J, Edwards H, et al. The Persistence of Racial Representation Disparity in Head and Neck Cancer Clinical Trials in the United States: A Temporal Analysis of 20 Years of Data. Head & Neck. 2026. doi:10.1002/hed.70197

BibTeX
@article{Sabat2026,
  author = {Sabat, Lalita and Barfejani, Arnavaz Hajizadeh and Chow, Grace and Zuckerman, Melani and Lee, Jungwun and Edwards, Heather and Krisciunas, Gintas P},
  title = {The Persistence of Racial Representation Disparity in Head and Neck Cancer Clinical Trials in the United States: A Temporal Analysis of 20 Years of Data},
  journal = {Head & Neck},
  year = {2026},
  doi = {10.1002/hed.70197}
}
Kostenlos starten →